mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.01 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.01 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |